Zimmer Holdings, Inc. - Form 8-K Summary
Business Context and Reporting Period
Date of Report: October 17, 2003
Company: Zimmer Holdings, Inc.
Event: Consummation of acquisition offers for Centerpulse AG and InCentive Capital AG (renamed SAICP AG).
On October 2, 2003, Zimmer completed the exchange of all outstanding registered shares and American Depositary Shares (ADSs) of Centerpulse AG, a leading Swiss medical technology group with over 2,800 employees serving reconstructive joint, spinal, and dental implant markets. Simultaneously, Zimmer acquired the majority of InCentive Capital AG, a Swiss investment company holding approximately 18.3% of Centerpulse.
Key Financial Metrics and Transaction Details
- Acquisition Scope: Zimmer acquired 98.7% of issued Centerpulse registered shares (including ADSs) and 99.9% of InCentive bearer shares.
- Total Consideration: Approximately 44,538,770 shares of Zimmer Common Stock and CHF 1,565 million in cash.
- Consideration Structure (Mix and Match):
- Standard Entitlement (Centerpulse): 3.68 Zimmer shares + CHF 120.00 cash per share.
- Max Stock Election (Centerpulse): 3.7947 Zimmer shares + CHF 112.83 cash per share.
- Max Cash Election (Centerpulse): CHF 350.00 cash per share.
- Standard Entitlement (InCentive): 3.8349 Zimmer shares + CHF 178.84 cash per share.
- Financing Sources: Cash portion funded via a revolving credit/term loan agreement and a 364-day credit agreement dated June 12, 2003, with JPMorgan Chase Bank as administrative agent.
Material Changes and Future Actions
Following the consummation of the offers, Zimmer initiated compulsory acquisition proceedings with Swiss authorities to acquire the remaining Centerpulse and InCentive shares. The company anticipates completing this compulsory acquisition during the first half of 2004, subject to regulatory approval.
Guidance, Outlook, and Risks
Financial Statements: The filing does not contain current period revenue, profit, or cash flow metrics for Zimmer. Required financial statements and pro forma information for the acquired business will be filed in an amendment to this 8-K within 60 days.
Risks and Contingencies: The completion of the full acquisition of Centerpulse is contingent upon the approval of relevant Swiss authorities for the compulsory acquisition of remaining shares.
Investor Verification Checklist
- Verify the final pro forma financial impact of the CHF 1,565 million cash outlay and 44.5 million share issuance on Zimmer's balance sheet and earnings per share.
- Confirm the status of the compulsory acquisition of remaining Centerpulse shares expected in the first half of 2004.
- Review the terms of the June 12, 2003 credit agreements (Exhibits 10.27 and 10.28) to assess debt covenants and interest rate exposure.
- Monitor the upcoming amendment to this 8-K for the required financial statements of the acquired business.